112 related articles for article (PubMed ID: 38770973)
21. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
[TBL] [Abstract][Full Text] [Related]
22. The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.
Jin Z; Liu Y
Heliyon; 2023 Sep; 9(9):e19816. PubMed ID: 37809459
[TBL] [Abstract][Full Text] [Related]
23. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up.
Toomey D; Smyth G; Condron C; Kelly J; Byrne AM; Kay E; Conroy RM; Broe P; Bouchier-Hayes D
Int J Cancer; 2003 Jan; 103(3):408-12. PubMed ID: 12471625
[TBL] [Abstract][Full Text] [Related]
24. Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1.
Deng Y; Guo W; Li G; Li S; Li H; Li X; Niu B; Song M; Zhang Y; Xu Z; Li F
J Breast Cancer; 2020 Feb; 23(1):20-35. PubMed ID: 32140267
[TBL] [Abstract][Full Text] [Related]
25. LncRNA CTBP1-AS2 Promotes Cell Proliferation in Hepatocellular Carcinoma by Regulating the miR-623/Cyclin D1 Axis.
Wang M; Zhao H
Cancer Biother Radiopharm; 2020 Dec; 35(10):765-770. PubMed ID: 32522013
[TBL] [Abstract][Full Text] [Related]
26. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
27. TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
Wang Y; Zhang Y; Ouyang J; Yi H; Wang S; Liu D; Dai Y; Song K; Pei W; Hong Z; Chen L; Zhang W; Liu Z; Mcleod HL; He Y
Cell Oncol (Dordr); 2023 Oct; ():. PubMed ID: 37902941
[TBL] [Abstract][Full Text] [Related]
28. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
Li Y; Zong J; Zhao C
Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
[TBL] [Abstract][Full Text] [Related]
29. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
31. IL-6 Mediates Macrophage Infiltration after Irradiation via Up-regulation of CCL2/CCL5 in Non-small Cell Lung Cancer.
Wang X; Yang X; Tsai Y; Yang L; Chuang KH; Keng PC; Lee SO; Chen Y
Radiat Res; 2017 Jan; 187(1):50-59. PubMed ID: 28054838
[TBL] [Abstract][Full Text] [Related]
32. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
Ding K; Jiang X; Wang Z; Zou L; Cui J; Li X; Shu C; Li A; Zhou J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240137
[TBL] [Abstract][Full Text] [Related]
33. Single-cell and spatial transcriptomics reveal POSTN
Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
[TBL] [Abstract][Full Text] [Related]
34. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
35. C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.
Wang C; Wang M; Xing B; Chi Z; Wang H; Lie C; Dong H
Onco Targets Ther; 2019; 12():5189-5200. PubMed ID: 31308691
[TBL] [Abstract][Full Text] [Related]
36. miR-539-3P inhibits proliferation and invasion of gastric cancer cells by targeting CTBP1.
Zhou J; Su M; Zhang H; Wang J; Chen Y
Int J Clin Exp Pathol; 2019; 12(5):1618-1625. PubMed ID: 31933979
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Li M; Riddle S; Zhang H; D'Alessandro A; Flockton A; Serkova NJ; Hansen KC; Moldovan R; McKeon BA; Frid M; Kumar S; Li H; Liu H; Caánovas A; Medrano JF; Thomas MG; Iloska D; Plecitá-Hlavatá L; Ježek P; Pullamsetti S; Fini MA; El Kasmi KC; Zhang Q; Stenmark KR
Circulation; 2016 Oct; 134(15):1105-1121. PubMed ID: 27562971
[TBL] [Abstract][Full Text] [Related]
38. MAT1A Suppression by the CTBP1/HDAC1/HDAC2 Transcriptional Complex Induces Immune Escape and Reduces Ferroptosis in Hepatocellular Carcinoma.
Li Y; Hu G; Huang F; Chen M; Chen Y; Xu Y; Tong G
Lab Invest; 2023 Aug; 103(8):100180. PubMed ID: 37230466
[TBL] [Abstract][Full Text] [Related]
39. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
Koukourakis MI; Giatromanolaki A; Kakolyris S; O'Byrne KJ; Apostolikas N; Skarlatos J; Gatter KC; Harris AL
Br J Cancer; 1998 May; 77(10):1696-703. PubMed ID: 9635852
[TBL] [Abstract][Full Text] [Related]
40. LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer.
Liu M; Cai R; Wang T; Yang X; Wang M; Kuang Z; Xie Y; Zhang J; Zheng Y
Ann Transl Med; 2021 Sep; 9(17):1392. PubMed ID: 34733944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
